Schedule 13G ownership disclosure

Zymeworks Inc

Common Stock · CUSIP: 98985Y108

Event date: 2025-12-31

Filing-level shares
2,519,243
Percent of class
3.4%
  • Morgan Stanley

    Shares: 2,519,243 · Class: 3.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000895421-26-000053
Form type
SCHEDULE 13G/A
Filer
MORGAN STANLEY
CIK
CIK 895421
Filed
Feb 12, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub